NextCure, Inc. (NXTC)
6.24
-0.15
(-2.35%)
USD |
NASDAQ |
Sep 01, 11:11
NextCure Total Liabilities (Quarterly) : 10.47M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.47M |
| March 31, 2026 | 11.26M |
| December 31, 2025 | 16.14M |
| September 30, 2025 | 15.97M |
| June 30, 2025 | 16.04M |
| March 31, 2025 | 11.28M |
| December 31, 2024 | 16.45M |
| September 30, 2024 | 14.75M |
| June 30, 2024 | 17.15M |
| March 31, 2024 | 16.11M |
| December 31, 2023 | 15.00M |
| September 30, 2023 | 13.49M |
| June 30, 2023 | 14.95M |
| March 31, 2023 | 13.59M |
| December 31, 2022 | 18.17M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.368M |
| June 30, 2022 | 8.174M |
| March 31, 2022 | 8.81M |
| December 31, 2021 | 9.00M |
| September 30, 2021 | 9.599M |
| June 30, 2021 | 11.76M |
| March 31, 2021 | 11.80M |
| December 31, 2020 | 12.92M |
| September 30, 2020 | 8.739M |
| June 30, 2020 | 11.57M |
| March 31, 2020 | 11.72M |
| December 31, 2019 | 34.68M |
| September 30, 2019 | 34.48M |
| June 30, 2019 | 34.46M |
| March 31, 2019 | 35.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.62M |
| Shareholders Equity (Quarterly) | 12.15M |
| Debt to Equity Ratio | 0.3529 |
| Current Ratio | 3.470 |
| Net Debt Paydown Yield | 4.78% |